BSE filing, NSE: CMMHOSP. Summary written from the filing by ALFA Finder's alert engine.
Chennai Meenakshi Multispeciality Hospital Ltd: key numbers
- Share price
- ₹34.00
- Market cap
- ₹25.39 Cr
- Revenue (annual)
- ₹37.04 Cr
- Net profit (annual)
- ₹-1.12 Cr
- P/E (TTM)
- -62.0×Sector 51.1×
- Promoter holding
- 57.10%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chennai Meenakshi Multispeciality Hospital Ltd
All →Chennai Meenakshi Multispeciality Hospital Board Meeting Date
Chennai Meenakshi Multispeciality Hospital will hold a board meeting on 2 November 2026 to consider quarterly and half-year unaudited results. Trading window remains closed from 1 October until 48 hours after results.
Chennai Meenakshi Multispeciality Hospital Board Meeting Outcome
Chennai Meenakshi Multispeciality Hospital Limited has reconstituted its Audit Committee and Stakeholders Relationship Committee following the recent cessation of certain directors from the Board.
Chennai Meenakshi Multispeciality Hospital Annual General Meeting
Chennai Meenakshi Multispeciality Hospital conducted its 36th Annual General Meeting on September 30, 2026, transacting ordinary and special business items via remote e-voting and AGM voting.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital has announced book closure dates from September 24 to September 30, 2026, for its 36th Annual General Meeting.
Chennai Meenakshi Multispeciality Hospital Annual Report
Chennai Meenakshi Multispeciality Hospital filed its 36th Annual Report and AGM Notice for the financial year 2025-26. The AGM is scheduled for September 30, 2026.
Chennai Meenakshi Multispeciality Hospital Annual General Meeting
Chennai Meenakshi Multispeciality Hospital Ltd has scheduled its 36th Annual General Meeting on September 30, 2026, to be conducted via video conferencing.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.